Ethyl 4-(2,4-difluorophenyl)-7-[1-(3-methyltriazol-4-yl)ethyl]-6,8-dihydro-5H-1,7-naphthyridine-2-carboxylate
C22H23F2N5O2 — CID 118902529
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 4-(2,4-difluorophenyl)-7-[1-(3-methyltriazol-4-yl)ethyl]-6,8-dihydro-5H-1,7-naphthyridine-2-carboxylate
Ethyl 4-(2,4-difluorophenyl)-7-[1-(3-methyltriazol-4-yl)ethyl]-6,8-dihydro-5H-1,7-naphthyridine-2-carboxylate (PubChem CID 118902529) has the molecular formula C22H23F2N5O2 and a molecular weight of 427.46 g/mol. Its IUPAC name is ethyl 4-(2,4-difluorophenyl)-7-[1-(3-methyltriazol-4-yl)ethyl]-6,8-dihydro-5H-1,7-naphthyridine-2-carboxylate.
Molecular Properties
| Compound Name | Ethyl 4-(2,4-difluorophenyl)-7-[1-(3-methyltriazol-4-yl)ethyl]-6,8-dihydro-5H-1,7-naphthyridine-2-carboxylate |
|---|---|
| PubChem CID | 118902529 |
| Molecular Formula | C22H23F2N5O2 |
| Molecular Weight | 427.46 g/mol |
| Exact Mass | 427.18 |
| IUPAC Name | ethyl 4-(2,4-difluorophenyl)-7-[1-(3-methyltriazol-4-yl)ethyl]-6,8-dihydro-5H-1,7-naphthyridine-2-carboxylate |
| SMILES | CCOC(=O)c1cc(-c2ccc(F)cc2F)c2c(n1)CN(C(C)c1cnnn1C)CC2 |
| InChI | InChI=1S/C22H23F2N5O2/c1-4-31-22(30)19-10-17(15-6-5-14(23)9-18(15)24)16-7-8-29(12-20(16)26-19)13(2)21-11-25-27-28(21)3/h5-6,9-11,13H,4,7-8,12H2,1-3H3 |
| InChIKey | DHEDPOYUIJATKG-UHFFFAOYSA-N |
| XLogP | 3.45 |
| TPSA | 73.14 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.46 |
| LogP ≤ 5 | 3.45 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118902529 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.